Skip to main content
. 2013 Jun;57(6):2496–2505. doi: 10.1128/AAC.02247-12

Fig 1.

Fig 1

Chemical structures of β-lactamase inhibitors. (a) Clavulanic acid; (b) tazobactam; (c) sulbactam; (d) avibactam; (e) schematic representation of the proposed pathway for avibactam inhibition.